Ruth Etzioni

Ruth Etzioni has developed statistical models to estimate the overdiagnosis potential and lead time bias in multi-cancer early detection testing, providing critical quantitative frameworks for understanding the true clinical benefit of MCED screening. Her microsimulation models project the population-level impact of MCED testing on cancer mortality, healthcare costs, and quality-adjusted life years. Her work on distinguishing genuine early detection benefit from length-biased sampling has been essential for interpreting MCED clinical trial results.